MiniMed Group Inc.

MMED | NASDAQ

Price Alert Chart Builder DCF Calculator

$18.28

-$0.97 (-5.04%)

At close: Oct 30, 2026, 4:00 PM ET

$18.28

$0.00 (0.00%)

After-hours: Oct 30, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $5.14B

Enterprise Value $5B

Beta -3.71

Average Volume 5.5M

Shares Outstanding (Diluted) 281M

Shares Change YoY N/A

Institutional Ownership 13.98%

Exchange NASDAQ

ISIN US60365F1093

Price Performance

Price Change 1M -6.1%

Price Change 3M 1.3%

Price Change 6M 51.0%

Price Change YTD N/A

Price Change 1Y N/A

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) -16.1%

1Y CAGR (ann.) N/A

5Y CAGR (ann.) N/A

All-Time CAGR -1.7%

Valuation

PE Ratio -16.62

Forward PE 29.27

PEG Ratio 0.15

Forward PEG -0.14

PS Ratio 1.60

Forward PS 1.50

PB Ratio 1.42

P/FCF Ratio -16.28

P/Adj. FCF Ratio -14.17

P/OCF Ratio -49.41

EV/Sales 1.55

EV/EBIT 454.10

EV/EBITDA 56.12

EV/FCF -15.81

Earnings Yield -6.0%

FCF Yield -6.1%

Adj. FCF Yield -7.1%

Financial Health

Net Cash $207M

Total Debt $59M

Cash & Short-Term Investments $207M

Total Assets $4.72B

Current Ratio 1.81

Quick Ratio 1.36

Debt / Equity Ratio 0.02

Debt / EBITDA 0.66

Debt / FCF -0.19

OCF / Debt -1.78

Interest Coverage 0.00

Altman Z-Score 3.63

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 53.9%

Operating Profit Margin 0.5%

EBITDA Margin 5.3%

Net Profit Margin -10.2%

FCF Margin -9.8%

Adj. FCF Margin -11.3%

SBC / Revenue 1.5%

SBC Impact (per share) -14.9%

Returns

Return on Assets -7.0%

Return on Equity -9.1%

Return on Invested Capital 0.4%

Return on Capital Employed 0.4%

Return on Tangible Assets -13.9%

Historical Growth (CAGR)

Revenue CAGR 3Y 11.4%

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -51.7%

EPS CAGR 5Y N/A

EPS CAGR 10Y N/A

FCF CAGR 3Y -81.0%

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 8

EPS Growth Next 3Y 84.8%

Revenue Growth Next 3Y 8.3%

Earnings Date Dec 30, 2026

EPS Estimate (next Q) $0.12

EPS Growth Est (next Q) N/A

Revenue Est (next Q) $825.2M

Revenue Growth Est (next Q) 9.7%

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $25.73

Price Target Upside 40.8%

Cash Flow

Operating Cash Flow $-105M

Free Cash Flow $-316M

Adj. Free Cash Flow $-363M

FCF Per Share -$1.12

OCF Per Share -$0.37

OCF/S Ratio -3.3%

Income Statement

Revenue $3.22B

Gross Profit $1.74B

Operating Income $17M

EBITDA $89M

Net Income $-329M

EPS (Diluted) -$1.10

Revenue / Employee $402.75K

Profit / Employee $-41.13K

Employees 8,000